Search Results

Nonsurgical Local Therapies for Lung Metastases and Non–Small Cell Lung Cancer

Clinical data examining the use of available treatment options for selected lung cancer cases.

By Thierry de Baere, MD

Digital Health in DVT: What Would Truly Help Guide Care and Research?

Insights into the digital tools that can help improve patient engagement and advance understanding in deep vein thrombosis care.

With Christiana Salami, MS; Bedros Taslakian, MD, MA, EBIR-EV, FCIRSE, FAHA; Osman Ahmed, MD; Ezana Azene, MD, PhD; and Dania Daye, MD, PhD

A Combination Approach to Mesenteric Venous Thrombosis

Using percutaneous transhepatic thrombectomy and pharmacological thrombolysis to treat this highly morbid condition.

By Wei Zhou, MD; Tam T. Huynh, MD; and Peter H. Lin, MD

Updates in SFA Atherectomy and Thrombectomy

New tools are emerging, but what about data?

By Sreekumar Madassery, MD, and Eric C. King, MD

Combination Locoregional and Immunotherapy in Practice

Beau B. Toskich, MD, leads Rony Avritscher, MD; Kirema Garcia-Reyes, MD; and Nora Tabori, MD, through a series of questions about their approaches to combining local therapy with immunotherapy, how/if recent data have impacted their decision-making, preferences on type of immunotherapy, emerging applications, and more.

BCLC Staging and Treatment Algorithm: Does It Cover All?

The Barcelona Clinic Liver Cancer staging system is a commonly used algorithm for the management of HCC; however, there are key deviations in contemporary practice.

By Altan Ahmed, MD, MSc; Richard Kim, MD; Daniel A. Anaya, MD, MSHCT, FACS; and Bela Kis, MD, PhD, FSIR

Splanchnic Venous Thrombosis: Challenges and Opportunities

The status of management choices for this uncommon disease state.

By Mehran Midia, MD, FRCP(C), and Mahmood K. Razavi, MD, FSIR

Guidelines for the Use of Optional (Retrievable and Convertible) Vena Cava Filters

A summary of the SIR multidisciplinary consensus statement.

By John A. Kaufman, MD

Liver-Directed Interventional Oncology: My Top 5 Technical Pearls

Experts provide their top technical tips for cTACE, portal vein embolization, drug-eluting embolic TACE, radiation segmentectomy, parenchyma-sparing Y-90 with flow diversion, challenging ablations, ablation of poorly visualized hepatic tumors, and treatment of parasitized extrahepatic arteries.

By Thierry de Baere, MD; Nadine Abi-Jaoudeh, MD, FSIR, CCRP; Robert J. Lewandowski, MD; Edward Kim, MD, FSIR; Raul N. Uppot, MD; Amanda Smolock, MD, PhD; David S. Wang, MD, FSIR; and Daniel Sze, MD, PhD

Uncomplicated Subacute Type B Dissections

Defining a protocol for timing and extent of intervention.

By Zhu Ting, MD, PhD, and Weiguo Fu, MD, PhD

TEVAR: Advances and Remaining Questions

By Edward Y. Woo, MD, and Ian M. Loftus, MD, FRCS, Guest Chief Medical Editors

The Future of Artificial Intelligence in Interventional Oncology

Potential applications of AI within IO include patient diagnosis, response prediction, and intraprocedural guidance, dependent upon standardized and responsible implementation.

By Helen Zhang, BS; Shreyas Kulkarni, BS; Zhicheng Jiao, PhD; and Harrison X. Bai, MD, MS

The Mechanical Environment of Peripheral Arteries

Advancing device design with improved mechanical testing and computational modeling.

By James E. Moore Jr, PhD; Scott Anderson, PE, BME; and Michael R. Moreno, PhD